Jim Cramer has built a strong reputation in the industry. He’s the Mad Money host who carefully picks growth stocks that have the potential to survive market ups and downs. When it…
Dividend stocks have been under pressure in the past few years due to the broader economy’s unpredictable swings. General Mills (NYSE:GIS | GIS Price Prediction), The Campbell’s Company (NASDAQ:CPB), and Pfizer (NYSE:PFE)…
Invesco High Dividend Low Volatility ETF (NYSEARCA:SPHD) generates its 4.71% yield – roughly three times the S&P 500’s current dividend – by holding a concentrated portfolio of 50 U.S. stocks selected for…
Pfizer (NYSE: PFE | PFE Price Prediction) and Teva Pharmaceutical Industries (NYSE: TEVA) just reported third-quarter earnings that reveal two pharmaceutical companies moving in opposite directions. Pfizer is stabilizing after its COVID…
These five stocks are potential total return champions that could offer investors a smooth ride in 2026, as we could see some major selling at some point next year.
Watch the Video I began the conversation with Lee by noting how rarely investors stop to consider how dramatically the upper ranks of the stock market have changed. When we looked back…
When the AI bubble bursts, Altria will look like a pretty good investment again. It has paid out billions in dividends over the years, and that is unlikely to stop.
The first thing that comes to mind when we speak about the S&P 500 is the biggest tech companies, high valuations, and fastest-moving giants. The S&P 500 is packed with the biggest…
Pre-Market Stock Futures: The futures are trading higher as the new week begins, with most investors and traders relieved that last week has come to a close. Hopes that an end to…
You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating cash income from their portfolio, but if you handle…
Our five top November high-yield picks have solid forward momentum and should hold their ground well, even if we experience a 10% or bigger correction.
Pfizer (NYSE: PFE | PFE Price Prediction) beat earnings expectations decisively this morning, posting adjusted EPS of $0.87 against a $0.64 consensus and revenue of $16.65 billion versus $16.50 billion expected. The…
Joel South The GLP-1 drug market has surged dramatically in the past four years, driven by soaring demand for weight-loss treatments that also tackle related conditions like diabetes and heart disease. Valued at over…
There’s no better way to generate passive income than dividend stocks. If a stock has a dividend yield higher than the common benchmark, such as the S&P 500, it could be a…
The democratization of investing started with discount brokers slashing commissions and advanced through no-transaction-fee trading on apps like Robinhood (NASDAQ:HOOD | HOOD Price Prediction) and Fidelity. Now, it no longer takes a…
